These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1989. Cuchural GJ; Snydman DR; McDermott L; Iannini PB; Hill GB; Cleary TJ; O'Keefe JP; Pierson CL; Rihs JD; Finegold SM Clin Ther; 1992; 14(1):122-36. PubMed ID: 1576621 [TBL] [Abstract][Full Text] [Related]
12. [In vitro activity of 9 antimicrobials against Bacteroides fragilis]. Betriu Cabecerán C; Cogollos Agruña R; García Alonso G; Agra Valero M Rev Clin Esp; 1988 Feb; 182(3):134-6. PubMed ID: 3285381 [No Abstract] [Full Text] [Related]
13. In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group. Snydman DR; Jacobus NV; McDermott LA Antimicrob Agents Chemother; 2008 Dec; 52(12):4492-6. PubMed ID: 18838581 [TBL] [Abstract][Full Text] [Related]
14. Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin. Sofianou D; Douboyas J; Papapanagiotou J; Paradelis AG Methods Find Exp Clin Pharmacol; 1982; 4(3):173-7. PubMed ID: 7121128 [TBL] [Abstract][Full Text] [Related]
15. A simple tube test for assessing antibiotic sensitivity of certain anaerobic bacteria. Shivers WF; Graber CD J Egypt Med Assoc; 1976; 59(1-2):150-4. PubMed ID: 1032368 [No Abstract] [Full Text] [Related]
16. Susceptibility of Bacteroides fragilis, Bacteroides thetaiotaomicron, and Fusobacteria in Antibacterial agents. Niederau W; Höffler U; Pulverer G Arzneimittelforschung; 1980; 30(12):2093-8. PubMed ID: 7194067 [TBL] [Abstract][Full Text] [Related]
17. [Activity of seven antimicrobial agents against "Bacteroides fragilis" (author's transl)]. Tytgat F Ann Microbiol (Paris); 1980; 131(1):39-44. PubMed ID: 6899739 [TBL] [Abstract][Full Text] [Related]
18. National survey on the susceptibility of Bacteroides Fragilis Group: report and analysis of trends for 1997-2000. Snydman DR; Jacobus NV; McDermott LA; Ruthazer R; Goldstein EJ; Finegold SM; Harrell LJ; Hecht DW; Jenkins SG; Pierson C; Venezia R; Rihs J; Gorbach SL Clin Infect Dis; 2002 Sep; 35(Suppl 1):S126-34. PubMed ID: 12173121 [TBL] [Abstract][Full Text] [Related]
19. Kinetics of antimicrobial activity of amoxycillin/clavulanic acid against Bacteroides fragilis group. García-Rodriguez JA; Garcia Sanchez JE; Munoz Bellido JL; Trujillano I J Chemother; 1989 Jul; 1(4 Suppl):76-7. PubMed ID: 16312311 [No Abstract] [Full Text] [Related]
20. [Influence of the inoculum effect on minimal inhibitory concentrations of 3 derivatives of 5-nitro-imidazole and 11 other antibiotics on Bacteroides fragilis]. Dusart G; Simeon de Buochberg M; Maillols H; Zuccarelli M; Attisso MA Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):685-9. PubMed ID: 3054748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]